ATE26276T1 - (1h-tetrazol-5-yl)-2(1h)-chinolinone. - Google Patents

(1h-tetrazol-5-yl)-2(1h)-chinolinone.

Info

Publication number
ATE26276T1
ATE26276T1 AT84103231T AT84103231T ATE26276T1 AT E26276 T1 ATE26276 T1 AT E26276T1 AT 84103231 T AT84103231 T AT 84103231T AT 84103231 T AT84103231 T AT 84103231T AT E26276 T1 ATE26276 T1 AT E26276T1
Authority
AT
Austria
Prior art keywords
quinolinones
tetrazole
quinolinone
tetrazol
cyano
Prior art date
Application number
AT84103231T
Other languages
English (en)
Inventor
Terry L Wright
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE26276T1 publication Critical patent/ATE26276T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
AT84103231T 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-2(1h)-chinolinone. ATE26276T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/478,965 US4735948A (en) 1983-03-25 1983-03-25 (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
EP84103231A EP0120483B1 (de) 1983-03-25 1984-03-23 (1H-Tetrazol-5-yl)-2(1H)-chinolinone

Publications (1)

Publication Number Publication Date
ATE26276T1 true ATE26276T1 (de) 1987-04-15

Family

ID=23902120

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84103231T ATE26276T1 (de) 1983-03-25 1984-03-23 (1h-tetrazol-5-yl)-2(1h)-chinolinone.

Country Status (17)

Country Link
US (1) US4735948A (de)
EP (1) EP0120483B1 (de)
JP (1) JPS59176276A (de)
KR (1) KR900003650B1 (de)
AT (1) ATE26276T1 (de)
AU (1) AU562115B2 (de)
CA (1) CA1241001A (de)
DE (1) DE3462895D1 (de)
DK (1) DK163238C (de)
ES (1) ES8601963A1 (de)
GR (1) GR81908B (de)
IE (1) IE57073B1 (de)
IL (1) IL71319A (de)
NO (1) NO841157L (de)
NZ (1) NZ207581A (de)
PT (1) PT78289B (de)
ZA (1) ZA842065B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
EP0267691A3 (de) * 1986-10-15 1989-08-23 Schering Corporation Verwendung von 1-substituierten Naphthyridin- und Pyridopyrazinderivaten für die Herstellung von Immunosuppressoren-arzneimittel.
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
GB9125485D0 (en) * 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
EP0670320A4 (de) * 1992-12-01 1997-05-02 Green Cross Corp 1,8-naphthyridin-2-on-derivat und seine verwendung.
DE19727410A1 (de) * 1997-06-27 1999-01-07 Hoechst Schering Agrevo Gmbh 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444369A (en) * 1973-04-05 1976-07-28 Allen & Hanburys Ltd 1,8-naphthyridines
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
KR900003650B1 (ko) 1990-05-28
EP0120483B1 (de) 1987-04-01
EP0120483A1 (de) 1984-10-03
ZA842065B (en) 1984-10-31
ES530877A0 (es) 1985-11-01
CA1241001A (en) 1988-08-23
NO841157L (no) 1984-09-26
DK163238B (da) 1992-02-10
DK165684D0 (da) 1984-03-23
KR840008153A (ko) 1984-12-13
JPS59176276A (ja) 1984-10-05
IE840720L (en) 1984-09-25
DK165684A (da) 1984-09-26
DK163238C (da) 1992-06-29
AU562115B2 (en) 1987-05-28
JPH0452273B2 (de) 1992-08-21
IL71319A0 (en) 1984-06-29
DE3462895D1 (de) 1987-05-07
AU2595284A (en) 1984-09-27
PT78289A (en) 1984-04-01
PT78289B (en) 1986-04-22
IL71319A (en) 1988-03-31
ES8601963A1 (es) 1985-11-01
GR81908B (de) 1984-12-12
NZ207581A (en) 1987-01-23
IE57073B1 (en) 1992-04-22
US4735948A (en) 1988-04-05

Similar Documents

Publication Publication Date Title
DK274788A (da) Tetrazoler
IT1199243B (it) Composti eterociclici,loro preparazione e loro impiego come medicamenti
IT1140523B (it) N-benzil-immidazoli come inibitori selettivi dell'enzima trombossano sintetasi,loro composizioni
ATE26276T1 (de) (1h-tetrazol-5-yl)-2(1h)-chinolinone.
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
DE3578744D1 (de) Natriumarmes, als kochsalzsubstitut geeignetes salzgemisch.
ES8609302A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
ATE26717T1 (de) (1h-tetrazol-5-yl)tetrazolo (1,5-a)chinoline und verwandte verbindungen.
IT1206359B (it) Perfezionamenti relativi ai mezzi e procedimento per la costruzione di edifici.
ATE18908T1 (de) 3-(1h-tetrazol-5-yl)-4(3h)-chinazolinone.
DE3568432D1 (de) Tetrazolothienopyridines
ATE50449T1 (de) (tetrazolyl)thienopyridone.
ATE30024T1 (de) Carbamate und oxalylamide von amino-n-(1htetrazol-5-yl)benzamiden.
CA1264325C (en) AROYLIMIDAZOLONES
NO985111L (no) Eksplosiv formulering
ES8801215A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzazepina
DE3485933T2 (de) Alkoxyiminoether-derivate von 5-acyl-2(1h)-pyridinonen.
IT8119427A0 (it) Composti eterociclici utili come agenti antiallergici.
SU866971A1 (ru) Циклопентено[d]тиазолил-2-гидразон n-нитробензальдегида, обладающий инсектицидной активностью